NCT00443313View on ClinicalTrials.gov

Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta

CompletedOBSERVATIONAL
Enrollment

664

Participants

Timeline

Start Date

January 24, 2007

Study Completion Date

June 25, 2015

Conditions
Cervical Intraepithelial Neoplasia
Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00443313 - Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta | Biotech Hunter | Biotech Hunter